fluconazole has been researched along with fusarium in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (16.67) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 15 (50.00) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anaissie, EJ; Bodey, GP; Bosso, J; Huls, C; Karl, C; Kontoyiannis, DP; Prince, RA; Vartivarian, SE | 1 |
| Engstrom, RE; Glasgow, BJ; Holland, GN; Kreiger, AE; Wool, MG | 1 |
| Kumar, BR; Kumar, RR; Lakshmaiah, KC; Shafiulla, M; Sridhar, H | 1 |
| Eagle, RC; Frayer, WC; Orlin, SE; Sulewski, ME; Weissgold, DJ | 1 |
| Andrew, SE; Brooks, DE; Dillavou, CL; Ellis, G; Kubilis, PS | 1 |
| Longley, BJ; Scher, RK; Treiber, RK; Tseng, SS | 1 |
| Hirai, H; Hori, A; Kami, M; Kanda, Y; Kashima, T; Machida, U; Matsumura, T; Mori Si, S; Mutou, Y; Okuzumi, K; Sakamaki, H; Takaue, Y; Yoneyama, A | 1 |
| Muzyka-Woźniak, M; Oficjalska-Młyńczak, J; Teklak, D; Turno-Krecicka, A | 1 |
| Appaji, L; Shafiulla, M; Sridhar, H; Subramanyam, JR; Vijaykumar, BR | 1 |
| Ferranti, S; Leonildi, A; Menichetti, F; Tascini, C | 1 |
| Guilhermetti, E; Shinobu, CS; Svidzinski, TI; Takahachi, G | 1 |
| Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M | 1 |
| Li, L; Li, R; Luo, S; Sun, X; Wang, Z | 1 |
| Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
| Baudraz-Rosselet, F; Bontems, O; Lurati, M; Monod, M; Ruffieux, C | 1 |
| Chabukswar, AR; Sangshetti, JN; Shinde, DB | 1 |
| Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
| He, B; Jia, H; Liu, Y; Ning, Y; Shi, X; Wang, C; Wang, J; Zheng, X | 1 |
| Li, S; Liu, J; Sun, X; Wang, K; Xie, B; Yu, X; Zhang, H; Zhou, F | 1 |
| Adil, SN; Ali, N; Shaikh, MU | 1 |
| Galletti, J; Grassi, FL; Kioshima-Cotica, ÉS; Negri, M; Svidzinski, TI | 1 |
| Durán, N; Longhi, C; Marcato, PD; Morey, AT; Nakazato, G; Pinge-Filho, P; Santos, JP; Yamada-Ogatta, SF; Yamauchi, LM | 1 |
| Bakhshi, S; Dabas, Y; Xess, I | 1 |
| Badiane, AS; Déme, A; Diallo, MA; Dieye, B; Diongue, K; Diop, A; Ndiaye, D; Ndiaye, IM; Ndiaye, JM; Ndiaye, M; Ndiaye, YD; Ndir, O; Ndoye, NW; Nguer, M; Seck, MC; Sow, AS | 1 |
| Carvalho, AO; de La Canal, L; Gomes, VM; Mello, ÉO; Pinedo, M; Regente, M; Rodrigues, R; Taveira, GB | 1 |
| Jabeen, N; Naz, SA; Shafique, M; Yaseen, M | 1 |
| Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
| Chandra, A; Gupta, MK; Prakash, P; Tilak, R | 1 |
| Chen, SC; Cornely, OA; Hoenigl, M; Jenks, JD; Thompson, GR | 1 |
| Dong, Y; Liu, Y; Ma, T; Mao, C; Wu, J; Zhang, C | 1 |
3 review(s) available for fluconazole and fusarium
| Article | Year |
|---|---|
Fusarium solani fungemia in a patient with acute lymphoblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Fluconazole; Fungemia; Fusarium; Humans; Immunocompromised Host; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2001 |
Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature.
Topics: Adolescent; Aged; Amphotericin B; Antifungal Agents; Base Sequence; DNA, Intergenic; Fluconazole; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; India; Male; Microbial Sensitivity Tests; Sequence Analysis, DNA; Shock, Septic | 2016 |
Breakthrough invasive fungal infections: Who is at risk?
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillus; Candida; Central Venous Catheters; Echinocandins; Fluconazole; Fusarium; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Mucorales; Mycoses; Neutropenia; Opportunistic Infections; Organ Transplantation; Penicillium; Risk Factors; Triazoles | 2020 |
1 trial(s) available for fluconazole and fusarium
| Article | Year |
|---|---|
Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections.
Topics: Adolescent; Adult; Aged; Aspergillus; Dose-Response Relationship, Drug; Female; Fluconazole; Fusarium; Humans; Immunocompromised Host; Immunosuppression Therapy; Male; Middle Aged; Mucorales; Mycoses; Neoplasms; Opportunistic Infections | 1995 |
26 other study(ies) available for fluconazole and fusarium
| Article | Year |
|---|---|
Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cytomegalovirus Retinitis; Endophthalmitis; Eye; Eye Infections, Fungal; Fluconazole; Fungemia; Fusarium; Humans; Male; Middle Aged; Mycoses | 1996 |
Fusarium solani infection in a patient with acute myelogenous leukemia--a case report.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Female; Fluconazole; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Necrosis; Skin | 1997 |
Delayed-onset fungal keratitis after endophthalmitis.
Topics: Acremonium; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cataract Extraction; Corneal Stroma; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Fusarium; Humans; Keratitis; Keratoplasty, Penetrating; Lenses, Intraocular; Male; Mycoses; Retrospective Studies; Vitrectomy | 1998 |
Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Topics: Analysis of Variance; Animals; Antifungal Agents; Aspergillus; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Fungal; Fluconazole; Fungi; Fusarium; Horse Diseases; Horses; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Natamycin; Penicillium | 1998 |
Fusarium fingernail infection responsive to fluconazole intermittent therapy.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Female; Fluconazole; Fusarium; Hand Dermatoses; Humans; Onychomycosis | 2000 |
Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Autopsy; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; Fusarium; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycology; Mycoses; Predictive Value of Tests; Regression Analysis; Sensitivity and Specificity; Trichosporon; Zygomycosis | 2002 |
[Vitrectomy in the treatment of endogenous fungal endophthalmitis in a patient after renal transplantation].
Topics: Amphotericin B; Antifungal Agents; Endophthalmitis; Fluconazole; Fusarium; Humans; Kidney Transplantation; Mycoses; Postoperative Complications; Vitrectomy | 2003 |
Breakthrough Fusarium sp probable pneumonia during fluconazole therapy in an AIDS patient with diabetes, candidemia, Pneumocystis carinii pneumonia and cytomegalovirus disseminated infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Cytomegalovirus Infections; Diabetes Mellitus, Type 1; Fatal Outcome; Fluconazole; Fungemia; Fusarium; Humans; Male; Middle Aged; Mycoses; Pneumonia; Pneumonia, Pneumocystis | 2006 |
Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Immunocompetence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine | 2007 |
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2008 |
In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Topics: Amphotericin B; Antifungal Agents; Corneal Diseases; Drug Evaluation; Drug Synergism; Eye; Eye Infections, Fungal; Fluconazole; Fusarium; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Natamycin; Terbinafine | 2008 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Topics: Acremonium; Adult; Antifungal Agents; Aspergillus; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Polymorphism, Restriction Fragment Length; Terbinafine | 2010 |
Microwave assisted one pot synthesis of some novel 2,5-disubstituted 1,3,4-oxadiazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Catalysis; Fluconazole; Fusarium; Miconazole; Microbial Sensitivity Tests; Microwaves; Oxadiazoles; Structure-Activity Relationship; Sulfites | 2011 |
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts | 2011 |
Minimal trephination penetrating keratoplasty for severe fungal keratitis complicated with hypopyon.
Topics: Adult; Aged; Antifungal Agents; Aspergillus; Candida albicans; Combined Modality Therapy; Cornea; Corneal Ulcer; Empyema; Eye Infections, Fungal; Female; Fluconazole; Fusarium; Humans; Keratoplasty, Penetrating; Male; Microscopy, Confocal; Middle Aged; Mycoses; Postoperative Complications; Retrospective Studies; Visual Acuity | 2013 |
Transcription factor CCG-8 as a new regulator in the adaptation to antifungal azole stress.
Topics: Antifungal Agents; Down-Regulation; Drug Resistance, Fungal; Fluconazole; Fusarium; Gene Expression Regulation, Fungal; Genes, Fungal; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa; Transcription Factors | 2014 |
Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Bacteremia; Candida albicans; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Ciprofloxacin; Developing Countries; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Female; Fluconazole; Fungemia; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pakistan; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Valacyclovir; Valine; Virus Diseases; Young Adult | 2014 |
Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients.
Topics: Antifungal Agents; Cross-Sectional Studies; Fluconazole; Fusariosis; Fusarium; Humans; Keratins; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Retrospective Studies; Terbinafine | 2015 |
Combination of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves antifungal effect against planktonic cells and biofilm of drug-resistant Candida albicans.
Topics: Antifungal Agents; Biofilms; Candida; Drug Resistance, Fungal; Fluconazole; Fusarium; Metal Nanoparticles; Plankton; Silver | 2016 |
[Keratomycosis due to Fusarium oxysporum treated with the combination povidone iodine eye drops and oral fluconazole].
Topics: Administration, Oral; Adult; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Fusarium; Humans; Male; Ophthalmic Solutions; Povidone-Iodine | 2015 |
Antimicrobial activity and mechanism of action of a thionin-like peptide from Capsicum annuum fruits and combinatorial treatment with fluconazole against Fusarium solani.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Capsicum; Cell Membrane; Cell Membrane Permeability; Fluconazole; Fruit; Fusarium; Humans; Hyphae; Thionins | 2017 |
Isolation of potentially pathogenic fungi from selected pigeons' feeding sites in Karachi: A new dimension to health hazard.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Columbidae; Drug Resistance, Fungal; Fluconazole; Fusarium; Microbial Sensitivity Tests; Pakistan; Penicillium; Rhizopus; Soil Microbiology | 2017 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
Topics: Antifungal Agents; Aspergillus; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Fungi; Fusarium; Humans; India; Itraconazole; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2018 |
Bioactivity of mefentrifluconazole against different Fusarium spp.
Topics: Fluconazole; Fungicides, Industrial; Fusarium; Mycelium; Oryza | 2022 |